extended interval dosing Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 4 (1)

Interventional (1)

VU University Medical Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadrelapsing multiple sclerosis

I am/have/hadmultiple sclerosis

I am/have/hadextended interval dosing

I am/have/hadprogressive multifocal leukoencephalopathy

I am/have/hadwhite matter disease

added new label for I am/have/had

more

I am looking for

I am looking fornatalizumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 4
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis

The influence of personalized dosing on pharmacokinetics will be monitored. Furthermore, personalized extended interval dosing will be studied in a subgroup with the aim to explore lower than previously studied trough values of natalizumab.

relapsing multiple sclerosis

multiple sclerosis

natalizumab

extended interval dosing

progressive multifocal leukoencephalopathy

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.